Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature (3)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (2)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biotechnology
Diseases
Drug discovery
Immunology
Microbiology
Neuroscience

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–3 of 3 results

Advanced filters: Author: Neil K. Savalia Clear advanced filters

Publisher Correction: Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors

Ling-Xiao Shao
Clara Liao
Alex C. Kwan
Amendments and Corrections29 Sept 2025
Nature

Volume: 646, P: E33
Psilocybin’s lasting action requires pyramidal cell types and 5-HT_2A receptors

A pyramidal cell type and the 5-HT_2A receptor in the medial frontal cortex have essential roles in psilocybin’s long-term drug action.

Ling-Xiao Shao
Clara Liao
Alex C. Kwan
Research02 Apr 2025
Nature

Volume: 642, P: 411-420
Diverse functional autoantibodies in patients with COVID-19

Rapid extracellular antigen profiling of a cohort of 194 individuals infected with SARS-CoV-2 uncovers diverse autoantibody responses that affect COVID-19 disease severity, progression and clinical and immunological characteristics.

Eric Y. Wang
Tianyang Mao
Aaron M. Ring
Research19 May 2021
Nature

Volume: 595, P: 283-288

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Filter By:

Publisher Correction: Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors

Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors

Diverse functional autoantibodies in patients with COVID-19

Search

Quick links

Psilocybin’s lasting action requires pyramidal cell types and 5-HT_2A receptors